• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
    • Why Should You Support SAGES?
    • SAGES Swag
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Annual Meeting
      • 2027 Scientific Session Call for Abstracts
      • 2027 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Lead Up Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • Innovative Surgical Trends
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Advanced Laparoscopy and Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
    • Foregut Video Atlas
  • Opportunities
    • Join the SAGES Patient Partner Network (PPN)
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs
  • Learning Hub
You are here: Home / Abstracts / Initial Experiences in 70 Cases of Totally Laparoscopic Liver Resection for Hcc

Initial Experiences in 70 Cases of Totally Laparoscopic Liver Resection for Hcc

Initial experiences in 70 cases of
Totally Laparoscopic Liver resection for HCC

Background
Laparoscopic surgery now is commonly applied for several kinds of different operations, but laparoscopic liver resection is still under survey. The objective of this study was to evaluate the feasibility and safety of this technique for HCC
Patients and methods
Perspective and descriptive study. From Sep 2005 to Feb 2008, we performed laparoscopic liver resections for 70 patients with HCC.The accompanied cirrhosis was in fifty two patients – 74% (51 with Child A and 1 with Child B); mean tumor size 3.75 cm (2-10) and tumor locations were as follows:

  • 31 (44.3%) in left lateral segment,
  • 4 (5.7 %) in segment IVb,
  • 13 (18.6%) in segment V,
  • 12 (17.1%) in segment VI,
  • 2 (2.9%) in segment VII,
  • 1 (1.4%) in segment VIII
  • 3 (4.3%) in the posterior segments
  • 4 (5.7%) in segment V and VI

Results
We performed 31 cases of one segmentectomy include:

  • 4 cases of segment II, 2 of segment III, 4 of segment IV, 8 of segment V, 11 of segment VI, 1 of segment VII and 1 of segment VIII.

There were 33 cases of bisegmentectomy include:

  • 24 (34.3%) cases of left lateral segmentectomies,
  • 3 (4.3%) posterior segmentectomy,
  • 6 (8.6%) V-VI bisegmentectomy.

After Laparoscopic Diagnostic operation, three (4,3%) patients were not suitable for liver resection because of severe cirrhosis. One of them underwent RFA and 2 had TACE after operation.
We had 3 (4.3%) patients converted to other procedures because of severe intraoperative bleeding. We converted to open operation after right hepatic vein was injured in one patient, or performed Minilaparotomy to control bleeding and continued to transect the parechymal laparoscopically in one, and converted to hand-assissted to define the tumor and divided the parechymal in the other.

Mean operation time was 118 minutes (30-240).

Mean Blood loss was 221 ml (0-1000ml) that required no blood transfusion.

Hospital stay was 6.23 days (4-17 days).

The Surgical margin less than 1cm was in 13 (18.5%) patients; from 1 to 2cm was in 37 (61.5%) and more than 2cm in 14 (20%) patients. But we had only one positive surgical margin.

There was no postoperative complication and no mortality.

After 10-month follow-up (1–31 months) there are 3 recurrence cases and two of them can be reoperated (one open and 1 laparscopic operations).

Conclusion:
Laparoscopic liver resection is feasible and safe for selective patients with peripheral tumors located in the left lobe or in the segment IVb, V, VI, VII of the right liver.


Session: Podium Presentation

Program Number: S017

Related



Hours & Info

15821 Ventura Blvd Ste 400
Encino, CA 91436

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2026 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

Refine Search